Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: Important differences between East and West

AIDS

Volumn 28, Issue 11, 2014, Pages 1657-1664

  Uusküla, Anneli ^a   Raag, Mait ^a   Folch, Cinta ^c   Prasad, Leoni ^d   Karnite, Anda ^e   Van Veen, Maaike G ^f   Eritsyan, Ksenia ^g   Rosinska, Magdalena ^h   Des Jarlais, Don C ^b   Wiessing, Lucas ⁱ  

^a UNIVERSITY OF TARTU   (Estonia)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d UNIVERSITY OF PORTO   (Portugal)

^e RIGA STRADINS UNIVERSITY   (Latvia)

^f DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^g ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^h NATIONAL MEDICINES INSTITUTE   (Poland)

ⁱ EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

Author keywords

Europe; HIV; HIV testing; Injection drug use; Risk behaviour

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; EASTERN EUROPE; FEMALE; HARM REDUCTION; HIGH RISK BEHAVIOR; HIGH RISK PATIENT; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PEOPLE WHO INJECT DRUG; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; SEXUAL BEHAVIOR; UNPROTECTED SEX; WESTERN EUROPE; COMPARATIVE STUDY; COMPLICATION; DIAGNOSTIC TEST; EUROPE; HIV INFECTIONS; META ANALYSIS; SUBSTANCE ABUSE; UTILIZATION;

ADULT; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TESTS, ROUTINE; EUROPE; EUROPE, EASTERN; FEMALE; HIV INFECTIONS; HUMANS; MALE; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84904685920     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000299     Document Type: Article

References (40)

1. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372: 1733-1745.
2. Bruce DR. Is it time for treatment as prevention among people who inject drugs? JAIDS 2013; 63: 545-547.
3. Reid SR. Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J 2009; 6: 24.
4. Asher AK, Hahn JA, Couture MC, Maher K, Page K. People who Inject Drugs, HIV Risk, and HIV Testing Uptake in Sub-Saharan Africa. J Assoc Nurses AIDS Care 2012; 24: e35-e44.
5. UNAIDS. World AIDS day report, 2011. How to get to zero: faster, smarter, better. http://www.unaids.org/en/media/unaids/contentassets/documents/ unaidspublication/2011/JC2216-World AIDSday-report-2011-en.pdf.
6. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2011. Stockholm: European Centre for Disease Prevention and Control; 2012.
7. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic.UNAIDS; 2013.
8. European drug report 2013: trends and developments. European Monitoring Centre for Drugs and Drug Addiction; 2013. http://www.emcdda.europa.eu/ attachements.cfm/att-213154-EN-TDAT13001ENN1.pdf.
9. Pharris A, Wiessing L, Sfetcu O, Hedrich D, Botescu A, Fotiou A, et al. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Euro Surveill 2011; 16: 48.
10. SchlumbergerMG, Desenclos JC, Papaevangelou G, Richardson SC, Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users. Eur J Epidemiol 1999; 15: 207-215.
11. Desenclos JC, Papaevangelou G, Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users. AIDS 1993; 7: 1371-1377.
12. Wiessing L, Likatavicius G, Klempova D, Hedrich D, Nardone A, Griffiths P. Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users. Am J Public Health 2009; 99: 1049-1052.
13. Hedrich D, Pirona A, Wiessing L. From margin to mainstream: the evolution of harm reduction responses to problem drug use in Europe. Drugs Educ Prev Policy 2008; 15: 503-517.
14. Des Jarlais DC, Pinkerton S, Hagan H, Guardino V, Feelemyer J, Cooper H, et al. 30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs. Adv Prevent Med 2013; 2013: 346372.
15. European Centre for Diseases Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC/EMCDDA; 2011.
16. Campbell JD, Herbst JH, Koppenhaver RT, Smith DK. Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV. Am J Prev Med 2013; 44 (1 Suppl 2): S63-S69.
17. Montaner JSG, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010; 376: 532-539.
18. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Trends in injecting drug use in Europe. Selected issue 2010. http://www.emcdda.europa. eu/attachements.cfm/att-108590-EN-EMCDDA-SI10-injecting.pdf.
19. Rondy M, Wiessing L, Hutchinson SJ, Mathei C, Mathis F, Mravcik V, et al. Hepatitis C prevalence in injecting drug users in Europe, 1990-2007: impact of study recruitment setting. Epidemiol Infect 2012; 17: 1-10.
20. Sutton AJ, Hope VD, Mathei C, Mravcik V, Sebakova H, Vallejo F, et al. A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study. J Viral Hepat 2008; 15: 809-816.
21. Folch C, Casabona J, Brugal MT, Majó X, Esteve A, Meroño M, et al. Sexually transmitted infections and sexual practices among injecting drug users recruited in harm reduction centers in Catalonia, Spain. Eur Addict Res 2011; 17: 271-278.
22. Karnte A, Brigis Ģ, Upmace I. Does the knowledge on HIV status change the risk behaviour of injecting drug users? Rgas Stradiņa universitātes Zinātniskie raksti 2011; 1: 225-233.
23. National Institute of Health Development, University of Tartu, Public Health Agency. Prevalence of HIV and other infections and risk behaviour among injecting drug users in Latvia, Lithuania and Estonia in 2007: study report; 2009. http://balthiv.com/noderiga-informacija/petijumi.
24. Vorobjov S, Des Jarlais DC, Abel-Ollo K, Talu A, Rüü tel K, Uuskü la A. Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: evidence from cross-sectional surveys. Int J Drug Policy 2013; 24: 150-155.
25. Czerwinski M, McNutt L-A, DeHovitz JA, Zielinski A, Rosinska M. Refining HIV risk: the modifying effects of youth, gender and education among people who inject drugs in Poland. PLoS One 2013; 8: e68018.
26. Eritsyan K, Heimer R, Barbour R, Odinokova V, White E, Rusakova MM, et al. Individual-level, network-level and citylevel factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study. BMJ Open 2013; 20: 3.
27. de Boer M, Op de Coul ELM, Beuker RJ, de Zwart O, Al Taqatqa W, van de Laar MJW. Trends in HIV prevalentie en risicogedrag onder injecterende druggebruikers in Rotterdam, 1994-2002 [in Dutch]. Ned Tijdschr Geneeskd 2004; 148: 2325-2330.
28. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-Analysis. Wiltshire, UK: Wiley; 2009.
29. Cochrane handbook for systematic reviews of interventions, version 5.1.0. Higgins JPT, Green S, editors (section 8.8.2.3). Meta-regression and comparisons of subgroups; 2011. http://handbook.cochrane.org/chapter-8/8-8-2-3- meta-regression-And-comparisons-of-subgroups.htm.
30. Wiessing L, Blystad H. EMCDDA publishes guidelines on testing for HIV, viral hepatitis and other infections in injecting drug users. Euro Surveill 2010; 15: 2010; 15: 48.
31. Sa'ez-Cirio'n A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, Lecuroux C, et al. Posttreatment HIV-1 controllers with a long-Term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog 2013; 9: e1003211.
32. Lodi S, Meyer L, Kelleher A, Rosińska M, Ghosn J, Sannes M, Porter K, for the CASCADE collaboration in EuroCoord. Immuno-virological control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion. Arch Intern Med 2012; 23: 1-4.
33. Swe LA, Nyo KK, Rashid A. Risk behaviours among HIV positive injecting drug users in Myanmar: a case control study. Harm Reduct J 2010; 7: 12.
34. Morineau G, Bollen LJ, Syafitri RI, Nurjannah N, Mustikawati DE, Magnani R. HIV prevalence and risk behaviours among injecting drug users in six Indonesian cities implications for future HIV prevention programs. Harm Reduct J 2012; 9: 37.
35. Rondinelli AJ, Ouellet LJ, Strathdee SA, Latka MH, Hudson SM, Hagan H, et al. Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend 2009; 104: 167-174.
36. Strathdee SA, Lozada R, Pollini RA, Brouwer KC, Mantsios A, Abramovitz DA, et al. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquir Immune Defic Syndr 2008; 47: 369-376.
37. Eluwa GI, Strathdee SA, Adebayo SB, Ahonsi B, Adebajo SB. A profile on HIV prevalence and risk behaviors among injecting drug users in Nigeria: should we be alarmed? Drug Alcohol Depend 2013; 127: 65-71.
38. Solomon SS, Srikrishnan AK, Mehta SH, Vasudevan CK, Murugavel KG, Thamburaj E, et al. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern. J Acquir Immune Defic Syndr 2008; 49: 327-332.
39. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ 2001; 165: 405-410.
40. European Centre for Disease Prevention and Control (ECDC), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC; 2011. http://www.emcdda.europa.eu/publications/ecdc-emcdda-gui dance.